Register entry
Journey Medical Corporation
- Registered sites
- 0
- Drug products
- 8
- Live patents
- 43
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
43Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| AMZEEQ | MINOCYCLINE HYDROCHLORIDE | Oct 2030 |
| AMZEEQ | MINOCYCLINE HYDROCHLORIDE | Sept 2037 |
| EMROSI | MINOCYCLINE HYDROCHLORIDE | Jan 2039 |
| QBREXZA | GLYCOPYRRONIUM TOSYLATE | Oct 2028 |
| QBREXZA | GLYCOPYRRONIUM TOSYLATE | Dec 2029 |
| QBREXZA | GLYCOPYRRONIUM TOSYLATE | Jul 2030 |
| QBREXZA | GLYCOPYRRONIUM TOSYLATE | Feb 2033 |
| XIMINO | MINOCYCLINE HYDROCHLORIDE | Mar 2027 |
| XIMINO | MINOCYCLINE HYDROCHLORIDE | Apr 2027 |
| ZILXI | MINOCYCLINE HYDROCHLORIDE | Oct 2030 |
Catalogue
Marketed products
8Showing 8 of 8.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| AMZEEQ | Minocycline | AEROSOL, FOAM | NDA |
| EMROSI | Minocycline Hydrochloride Extended-Release | CAPSULE | NDA |
| Eurax | crotamiton | CREAM | NDA |
| Exelderm | Sulconazole Nitrate | CREAM | NDA |
| Exelderm | Sulconazole Nitrate | SOLUTION | NDA |
| Qbrexza | glycopyrronium | CLOTH | NDA |
| TARGADOX | doxycycline hyclate | TABLET | ANDA |
| ZILXI | Minocycline | AEROSOL, FOAM | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.